Klein Matthew B.

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
21
Insider Sells Sum
$3.01M

Insider Activity of Klein Matthew B.

According to the SEC Form 4 filings, Klein Matthew B., being in a position of

  1. CHIEF EXECUTIVE OFFICER at PTC Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 25283 shares for $1.08M,
    over all time since 2021-01-07, has bought 0 shares, and sold 67387 shares for $3.01M.

The largest sale of all time was on 2021-01-08 and amounted to 5500 shares of PTC Therapeutics, Inc. for $383,410.

Biography of Klein Matthew B.

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Prismo
Buys
 $000
Sells
 $1,084,8647100

Comparison of Insiders on Amount of Buys and Sells

Prismo
Prismo
2025-02-20SalePTC Therapeutics, Inc.
PTCT
CHIEF EXECUTIVE OFFICER
3,895
0.005%
$50.12$195,233+4.62%
2025-02-19SalePTC Therapeutics, Inc.
PTCT
CHIEF EXECUTIVE OFFICER
3,897
0.0051%
$50.10$195,224+3.93%
2025-01-08SalePTC Therapeutics, Inc.
PTCT
CHIEF EXECUTIVE OFFICER
2,402
0.0031%
$44.50$106,889+10.8%
2025-01-07SalePTC Therapeutics, Inc.
PTCT
CHIEF EXECUTIVE OFFICER
2,142
0.0028%
$45.34$97,118+11.68%
2024-12-31SalePTC Therapeutics, Inc.
PTCT
CHIEF EXECUTIVE OFFICER
8,279
0.0107%
$45.16$373,880+10.04%
2024-04-19SalePTC Therapeutics, Inc.
PTCT
CHIEF EXECUTIVE OFFICER
3,361
0.0043%
$24.89$83,669+48.74%
2024-04-17SalePTC Therapeutics, Inc.
PTCT
CHIEF EXECUTIVE OFFICER
1,307
0.0017%
$25.14$32,851+49.48%
2024-01-09SalePTC Therapeutics, Inc.
PTCT
CHIEF EXECUTIVE OFFICER
5,443
0.0073%
$29.01$157,928+17%
2024-01-08SalePTC Therapeutics, Inc.
PTCT
CHIEF EXECUTIVE OFFICER
2,237
0.0029%
$28.64$64,068+11.97%
2024-01-05SalePTC Therapeutics, Inc.
PTCT
CHIEF EXECUTIVE OFFICER
10,107
0.013%
$27.15$274,393+20.04%
2023-04-18SalePTC Therapeutics, Inc.
PTCT
CHIEF EXECUTIVE OFFICER
1,211
0.0016%
$52.04$63,025-45.6%
2023-01-11SalePTC Therapeutics, Inc.
PTCT
CHIEF OPERATING OFFICER
2,244
0.003%
$44.36$99,543-10.8%
2023-01-10SalePTC Therapeutics, Inc.
PTCT
CHIEF OPERATING OFFICER
2,273
0.003%
$42.93$97,586-7.73%
2023-01-09SalePTC Therapeutics, Inc.
PTCT
CHIEF OPERATING OFFICER
731
0.001%
$41.66$30,451-1.51%
2022-04-19SalePTC Therapeutics, Inc.
PTCT
CHIEF OPERATING OFFICER
897
0.0012%
$42.52$38,136+2%
2022-01-07SalePTC Therapeutics, Inc.
PTCT
Chief Operating Officer
775
0.0011%
$38.52$29,857+5.33%
2021-04-20SalePTC Therapeutics, Inc.
PTCT
Chief Development Officer
1,641
0.0024%
$46.74$76,704-13.86%
2021-04-19SalePTC Therapeutics, Inc.
PTCT
Chief Development Officer
859
0.0012%
$48.17$41,376-16.09%
2021-01-15SalePTC Therapeutics, Inc.
PTCT
Chief Development Officer
4,300
0.0062%
$69.09$297,078-39.79%
2021-01-08SalePTC Therapeutics, Inc.
PTCT
Chief Development Officer
5,500
0.0081%
$69.71$383,410-38.46%
Total: 21
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Sells over the last 12 months, USD